{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:15:43Z","timestamp":1785417343271,"version":"3.56.0"},"reference-count":103,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002349","name":"Academy of Scientific Research and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002349","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/02k284p70","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science, Technology & Innovation Funding Authority","doi-asserted-by":"publisher","award":["22868"],"award-info":[{"award-number":["22868"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Glioblastoma multiforme (GBM) is the most aggressive brain tumor in adults. Necrosis, and by inference hypoxia, is a pathognomonic feature of GBM tumors, where hypoxia significantly contributes to chemoresistance, leading to local treatment failure and disease progression. Although temozolomide (TMZ) is the main treatment option, 60\u201375% of GBM patients do not benefit from it. This study aimed to evaluate the therapeutic potential of Tetrandrine (TET) in combination with or compared to TMZ in treating GBM cells (M010b and U87) under both normoxic and hypoxic conditions. The therapeutic potential was assessed using qRT-PCR, MTT assay, combination index analysis, flow cytometry for apoptosis and cell cycle analysis, scratch assay, gelatin zymography, measurement of mitochondrial membrane potential (\u0394\u03a8m), reactive oxygen species (ROS) production, and molecular docking. Under both normoxic and hypoxic conditions, TET showed significant cytotoxicity in both cell lines compared to TMZ. A synergistic effect was observed only under normoxia at 2\u00d7 IC50 concentrations in M010b cells, and at 4\u00d7 IC50 concentrations in U87 cells. TET significantly increased the sub-G1 cell population and apoptosis compared to TMZ in both cell lines under normoxic and hypoxic conditions, while TMZ induced G2\/M arrest in U87 cells under both conditions. TET significantly increased ROS production in both cell lines under normoxia. Under both conditions, \u0394\u03a8m was significantly reduced by TET in M010b cells and by TMZ in both cell lines. TET and TMZ significantly reduced pro-MMP-2 levels in M010b cells under both conditions and in U87 cells under normoxia. In conclusion, given the limited therapeutic potential of TMZ, our findings suggest that TET could be a viable alternative treatment option for GBM.<\/jats:p>","DOI":"10.3390\/ijms27115090","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:23:21Z","timestamp":1780622601000},"page":"5090","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Potential of Tetrandrine Compared to Temozolomide in Treating Glioblastoma Multiforme Under Normoxic and Hypoxic Conditions"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9332-864X","authenticated-orcid":false,"given":"Mona A.","family":"Khamis","sequence":"first","affiliation":[{"name":"Center for Aging and Associated Diseases, Zewail City of Science, Technology and Innovation, Giza 12578, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Abdo","sequence":"additional","affiliation":[{"name":"Center for Aging and Associated Diseases, Zewail City of Science, Technology and Innovation, Giza 12578, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9135-3818","authenticated-orcid":false,"given":"Fatma G.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Chemistry Department (Biochemistry Division), Faculty of Science, Cairo University, Giza 12613, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9499-1655","authenticated-orcid":false,"given":"Marwan","family":"Emara","sequence":"additional","affiliation":[{"name":"Center for Aging and Associated Diseases, Zewail City of Science, Technology and Innovation, Giza 12578, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ch\u00e9deville, A.L., Lourdusamy, A., Monteiro, A.R., Hill, R., and Madureira, P.A. (2020). Investigating glioblastoma response to hypoxia. Biomedicines, 8.","DOI":"10.3390\/biomedicines8090310"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.bbrc.2020.10.058","article-title":"Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells","volume":"533","author":"Bagca","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Park, J.H., and Lee, H.K. (2022). Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy. Cancers, 14.","DOI":"10.3390\/cancers14051176"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yalamarty, S.S.K., Filipczak, N., Li, X., Subhan, M.A., Parveen, F., Ataide, J.A., Rajmalani, B.A., and Torchilin, V.P. (2023). Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM). Cancers, 15.","DOI":"10.3390\/cancers15072116"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/curroncol31070296","article-title":"Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme\u2014A Literature Review and Clinical Outcomes","volume":"31","author":"Nafalska","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phymed.2018.09.220","article-title":"Isofuranodiene synergizes with temozolomide in inducing glioma cells death","volume":"52","author":"Brunetti","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1586\/ern.10.32","article-title":"Temozolomide: Therapeutic limitations in the treatment of adult high-grade gliomas","volume":"10","author":"Chamberlain","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/chemistry6050060","article-title":"Advancements in Microfluidic Platforms for Glioblastoma Research","volume":"6","author":"Raman","year":"2024","journal-title":"Chemistry"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ren, P., Wang, J.Y., Zeng, Z.R., Li, N.X., Chen, H.L., Peng, X.G., Bhawal, U.K., and Guo, W.Z. (2022). A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.976356"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1158\/0008-5472.CAN-03-2424","article-title":"Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding","volume":"64","author":"Evans","year":"2004","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1667\/RR1207.1","article-title":"Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors","volume":"170","author":"Evans","year":"2008","journal-title":"Radiat. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7150\/thno.41692","article-title":"Glioma stem cells and their roles within the hypoxic tumor microenvironment","volume":"11","author":"Boyd","year":"2021","journal-title":"Theranostics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0360-3016(02)04507-8","article-title":"Inhibition of hypoxia inducible factor 1\u03b1 causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells","volume":"55","author":"Dai","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1128\/MCB.24.7.2875-2889.2004","article-title":"Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance","volume":"24","author":"Erler","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Strese, S., Frykn\u00e4s, M., Larsson, R., and Gullbo, J. (2013). Effects of hypoxia on human cancer cell line chemosensitivity. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-331"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.ejca.2009.07.010","article-title":"Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1\u03b1 involvement in CYP3A4 repression","volume":"45","author":"Legendre","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/13880209.2021.2017468","article-title":"Deciphering the molecular mechanism of tetrandrine in inhibiting hepatocellular carcinoma and increasing sorafenib sensitivity by combining network pharmacology and experimental evaluation","volume":"60","author":"Niu","year":"2022","journal-title":"Pharm. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.gendis.2019.10.017","article-title":"Tetrandrine inhibits proliferation of colon cancer cells by BMP9\/PTEN\/PI3K\/AKT signaling","volume":"8","author":"Zhou","year":"2021","journal-title":"Genes Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/jphp.12935","article-title":"Anticancer activity of tetrandrine by inducing pro-death apoptosis and autophagy in human gastric cancer cells","volume":"70","author":"Bai","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bbrc.2019.04.075","article-title":"Tetrandrine induces apoptosis in human neuroblastoma through regulating the Hippo\/YAP signaling pathway","volume":"513","author":"Zhao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1158\/1535-7163.MCT-17-1157","article-title":"Tetrandrine (TET) Induces Death Receptors Apo Trail R1 (DR4) and Apo Trail R2 (DR5) and Sensitizes Prostate Cancer Cells to TRAIL-Induced Apoptosis","volume":"17","author":"Shishodia","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3892\/ijo.2014.2800","article-title":"The role of IGFBP-5 in mediating the anti-proliferation effect of tetrandrine in human colon cancer cells","volume":"46","author":"Wu","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100063","DOI":"10.1016\/j.synres.2020.100063","article-title":"Combination of tetrandrine and cisplatin synergises cytotoxicity and apoptosis in triple negative breast cancer","volume":"10","author":"Bhagya","year":"2020","journal-title":"Synergy"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"BSR20182109","DOI":"10.1042\/BSR20182109","article-title":"Tetrandrine inhibits colon carcinoma HT-29 cells growth via the Bcl-2\/Caspase 3\/PARP pathway and G1\/S phase","volume":"39","author":"Li","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Liao, C.-L., Ma, Y.-S., Hsia, T.-C., Chou, Y.-C., Lien, J.-C., Peng, S.-F., Kuo, C.-L., and Hsu, F.-T. (2021). Tetrandrine Suppresses Human Brain Glioblastoma GBM 8401\/luc2 Cell-Xenografted Subcutaneous Tumors in Nude Mice In Vivo. Molecules, 26.","DOI":"10.3390\/molecules26237105"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Liao, D., Zhang, W., Gupta, P., Lei, Z.N., Wang, J.Q., Cai, C.Y., De Vera, A.A., Zhang, L., Chen, Z.S., and Yang, D.H. (2019). Tetrandrine interaction with ABCB1 reverses multidrug resistance in cancer cells through competition with anti-cancer drugs followed by downregulation of ABCB1 expression. Molecules, 24.","DOI":"10.3390\/molecules24234383"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3892\/ijo.2014.2735","article-title":"Tetrandrine induces G1\/S cell cycle arrest through the ROS\/Akt pathway in EOMA cells and inhibits angiogenesis in vivo","volume":"46","author":"Xiao","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"173575","DOI":"10.1016\/j.ejphar.2020.173575","article-title":"Tetrandrine enhances antitumor effects of the histone deacetylase inhibitor MS-275 in human cancer in a Bax- and p53-dependent manner","volume":"888","author":"Li","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13046-018-0779-2","article-title":"Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy","volume":"37","author":"Yu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/bph.13045","article-title":"Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: A potential antagonistic role for p21","volume":"172","author":"Mei","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00280-007-0416-9","article-title":"Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines","volume":"60","author":"Wei","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bcp.2014.08.014","article-title":"c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL\/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine","volume":"91","author":"Chaudhary","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2011.01.022","article-title":"Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo","volume":"304","author":"Zhang","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/bjc.2013.334","article-title":"Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)\/Akt signaling","volume":"109","author":"Wan","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/ijc.24208","article-title":"Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats","volume":"124","author":"Chen","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejphar.2015.06.017","article-title":"Tetrandrine suppresses human glioma growth by inhibiting cell survival, proliferation and tumour angiogenesis through attenuating STAT3 phosphorylation","volume":"764","author":"Ma","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jat.3749","article-title":"The use of cobalt chloride as a chemical hypoxia model","volume":"39","year":"2019","journal-title":"J. Appl. Toxicol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"ref_40","unstructured":"Dhawan, A., and Kwon, S. (2018). Chapter\u2014Models and Methods for In Vitro Toxicity. In Vitro Toxicology, Academic Press."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.tiv.2003.12.004","article-title":"Flow cytometric methods used as screening tests for basal toxicity of chemicals","volume":"18","author":"Tuschl","year":"2004","journal-title":"Toxicol. Vitr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/sj.bjc.6603663","article-title":"Apoptosis assays with lymphoma cell lines: Problems and pitfalls","volume":"96","author":"Mattes","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: Current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Shoari, A., Ashja Ardalan, A., Dimesa, A.M., and Coban, M.A. (2024). Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy. Biomolecules, 15.","DOI":"10.3390\/biom15010035"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jphp.13339","article-title":"Tetrandrine: A review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems","volume":"72","author":"Luan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jscs.2010.02.005","article-title":"Cobalt chloride, a chemical inducer of hypoxia-inducible factor-1\u03b1 in U251 human glioblastoma cell line","volume":"14","year":"2010","journal-title":"J. Saudi Chem. Soc."},{"key":"ref_47","first-page":"111848","article-title":"Evaluation of the effects of simulated hypoxia by CoCl2 on radioresistance and change of hypoxia-inducible factors in human glioblastoma U87 tumor cell line","volume":"828","author":"Khakshour","year":"2024","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102408","DOI":"10.1016\/j.tice.2024.102408","article-title":"Differential effects of coverslip-induced hypoxia and cobalt chloride mimetic hypoxia on cellular stress, metabolism, and nuclear structure","volume":"88","author":"Lamela","year":"2024","journal-title":"Tissue Cell"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Lo Dico, A., Martelli, C., Diceglie, C., Lucignani, G., and Ottobrini, L. (2018). Hypoxia-inducible factor-1\u03b1 activity as a switch for glioblastoma responsiveness to temozolomide. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00249"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Di Ianni, N., Maffezzini, M., Eoli, M., and Pellegatta, S. (2021). Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.747690"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/s41419-018-1176-7","article-title":"Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a\/Bad\/Bax axis","volume":"9","author":"Ge","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"17392","DOI":"10.1002\/jcp.28361","article-title":"Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1\u03b1\/hedgehog pathway under hypoxia","volume":"234","author":"Wei","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/tox.22691","article-title":"Tetrandrine inhibits human brain glioblastoma multiforme GBM 8401 cancer cell migration and invasion in vitro","volume":"34","author":"Jiang","year":"2019","journal-title":"Environ. Toxicol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s13277-013-1293-y","article-title":"Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17","volume":"35","author":"Wu","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"ref_56","first-page":"60","article-title":"Cell Cycle and Cancer","volume":"36","author":"Park","year":"2003","journal-title":"J. Biochem. Mol. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.biopha.2017.10.116","article-title":"Tetrandrine and cancer\u2014An overview on the molecular approach","volume":"97","author":"Bhagya","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_58","first-page":"17","article-title":"Mechanisms of temozolomide resistance in glioblastoma\u2014A comprehensive review","volume":"4","author":"Singh","year":"2021","journal-title":"Cancer Drug Resist."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2217\/nnm-2017-0395","article-title":"Hyperbaric oxygen as an adjuvant to temozolomide nanoparticle inhibits glioma growth by inducing G2\/M phase arrest","volume":"13","author":"Xie","year":"2018","journal-title":"Nanomedicine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/sj.bjc.6601193","article-title":"Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide","volume":"89","author":"Kanzawa","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Barciszewska, A.M., Gurda, D., G\u0142odowicz, P., Nowak, S., and Naskr\u0119t-Barciszewska, M.Z. (2015). A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0136669"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Perazzoli, G., Prados, J., Ortiz, R., Caba, O., Cabeza, L., Berdasco, M., G\u00f3nzalez, B., and Melguizo, C. (2015). Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140131"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Dhungel, L., Rowsey, M.E., Harris, C., and Raucher, D. (2024). Synergistic Effects of Temozolomide and Doxorubicin in the Treatment of Glioblastoma Multiforme: Enhancing Efficacy through Combination Therapy. Molecules, 29.","DOI":"10.3390\/molecules29040840"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/01635581.2014.902974","article-title":"Tetrandrine and caffeine modulated cell cycle and increased glioma cell death via caspase-dependent and caspase-independent apoptosis pathways","volume":"66","author":"Chen","year":"2014","journal-title":"Nutr. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4062\/biomolther.2016.044","article-title":"Tetrandrine exerts a radiosensitization effect on human glioma through inhibiting proliferation by attenuating ERK phosphorylation","volume":"25","author":"Ma","year":"2017","journal-title":"Biomol. Ther."},{"key":"ref_66","first-page":"1522","article-title":"The study of anti-tumor effect of Tetrandrine combined with Nedaplatin on human liver cancer cell line 7402","volume":"31","author":"Deng","year":"2008","journal-title":"Zhong Yao Cai"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lin, Y.J., Peng, S.F., Lin, M.L., Kuo, C.L., Lu, K.W., Liao, C.L., Ma, Y.S., Chueh, F.S., Liu, K.C., and Yu, F.S. (2016). Tetrandrine induces apoptosis of human nasopharyngeal carcinoma npc-Tw 076 cells through reactive oxygen species accompanied by an endoplasmic reticulum stress signaling pathway. Molecules, 21.","DOI":"10.3390\/molecules21101353"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1038\/onc.2008.82","article-title":"Mechanism of G1-like arrest by low concentrations of paclitaxel: Next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis","volume":"27","author":"Demidenko","year":"2008","journal-title":"Oncogene"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.3748\/wjg.v11.i22.3451","article-title":"Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide","volume":"11","author":"Shao","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_70","unstructured":"Gray, S.G. (2015). Chapter 12\u2014Liver Cancer (Hepatocellular Carcinoma). Epigenetic Cancer Therapy, Academic Press."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tcb.2025.06.001","article-title":"Time as a danger signal promoting G1 arrest after mitosis","volume":"36","author":"Fulcher","year":"2025","journal-title":"Trends Cell Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41374-021-00666-7","article-title":"Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O6-methylguanine DNA methyltransferase (MGMT) expression and reactive oxygen species (ROS)-mediated DNA damage in glioblastoma","volume":"102","author":"Jin","year":"2022","journal-title":"Lab. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Chen, Z., Kim, S.N., Gan, C., Ryl, T., Lesjak, M.S., Rodemerk, J., De Zhong, R., Wrede, K., and Dammann, P. (2022). Characterization of Temozolomide Resistance Using a Novel Acquired Resistance Model in Glioblastoma Cell Lines. Cancers, 14.","DOI":"10.3390\/cancers14092211"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3892\/ijo.2016.3780","article-title":"Tetrandrine inhibits glioma stem-like cells by repressing \u03b2-catenin expression","volume":"50","author":"Zhang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/wsbm.1595","article-title":"Intracellular and microenvironmental regulation of mitochondrial membrane potential in cancer cells","volume":"15","author":"Begum","year":"2023","journal-title":"WIREs Mech. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.2147\/OTT.S174498","article-title":"Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage","volume":"11","author":"Liu","year":"2018","journal-title":"Onco Targets Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/tox.22238","article-title":"Tetrandrine induces programmed cell death in human oral cancer CAL 27 cells through the reactive oxygen species production and caspase-dependent pathways and associated with beclin-1-induced cell autophagy","volume":"32","author":"Lien","year":"2017","journal-title":"Environ. Toxicol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12935-024-03410-5","article-title":"Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer","volume":"24","author":"Wang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.25817","article-title":"Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma","volume":"129","author":"Liu","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Oliva, C.R., Moellering, D.R., Gillespie, G.Y., and Griguer, C.E. (2011). Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024665"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"100748","DOI":"10.1016\/j.tranon.2020.100748","article-title":"Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma","volume":"13","author":"Wu","year":"2020","journal-title":"Transl. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3892\/or.2014.3342","article-title":"Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT\/mTOR signaling","volume":"32","author":"Yin","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1755-5949.2012.00319.x","article-title":"Resveratrol Enhances the Antitumor Effects of Temozolomide in Glioblastoma via ROS-dependent AMPK-TSC-mTOR Signaling Pathway","volume":"18","author":"Yuan","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Ludke, A., Akolkar, G., Ayyappan, P., Sharma, A.K., and Singal, P.K. (2017). Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179452"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Al-Hayali, M., Garces, A., Stocks, M., Collins, H., and Bradshaw, T.D. (2021). Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity. Molecules, 26.","DOI":"10.3390\/molecules26175136"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","article-title":"Tumour-cell invasion and migration: Diversity and escape mechanisms","volume":"3","author":"Friedl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"101240","DOI":"10.1016\/j.imu.2023.101240","article-title":"Bioinformatic analysis of MMP family members in GBM","volume":"39","author":"Karimi","year":"2023","journal-title":"Inform. Med. Unlocked"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4103\/0973-1482.187241","article-title":"Synergistic effect of temozolomide and thymoquinone on human glioblastoma multiforme cell line (U87MG)","volume":"14","author":"Pazhouhi","year":"2018","journal-title":"J. Cancer Res. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.3892\/mmr.2016.5964","article-title":"Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells","volume":"14","author":"Wang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s11033-019-05219-2","article-title":"Effects of temozolomide on U87MG glioblastoma cell expression of CXCR4, MMP2, MMP9, VEGF, anti-proliferatory cytotoxic and apoptotic properties","volume":"47","author":"Mirabdaly","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jocn.2017.03.048","article-title":"Temozolomide does not influence the transcription or activity of matrix metalloproteinases 9 and 2 in glioma cell lines","volume":"41","author":"Suzuki","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Wen, X., Huang, A., Liu, Z., Liu, Y., Hu, J., Liu, J., and Shuai, X. (2014). Downregulation of ROCK2 through nanocomplex sensitizes the cytotoxic effect of temozolomide in U251 glioma cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092050"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Manganelli, V., Misasi, R., Riitano, G., Capozzi, A., Mattei, V., Caglar, T.R., Ialongo, D., Madia, V.N., Messore, A., and Costi, R. (2023). Role of a Novel Heparanase Inhibitor on the Balance between Apoptosis and Autophagy in U87 Human Glioblastoma Cells. Cells, 12.","DOI":"10.3390\/cells12141891"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12079-020-00551-w","article-title":"LRP6 mediated signal transduction pathway triggered by tissue plasminogen activator acts through lipid rafts in neuroblastoma cells","volume":"14","author":"Riitano","year":"2020","journal-title":"J. Cell Commun. Signal"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.bjc.6690328","article-title":"Modulation of oxygen consumption rate and vascular endothelial growth factor mRNA expression in human malignant glioma cells by hypoxia","volume":"80","author":"Franko","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1097\/01.coc.0000091359.11281.f4","article-title":"Influence of Oxygen on the Radiosensitivity of Human Glioma Cell Lines","volume":"26","author":"Murray","year":"2003","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3892\/or.2014.3037","article-title":"Effect of hypoxia on angiogenesis related factors in glioblastoma cells","volume":"31","author":"Emara","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_98","first-page":"975","article-title":"Myoglobin variants are expressed in human glioblastoma cells-hypoxia effect?","volume":"43","author":"Elkholi","year":"2020","journal-title":"Oncol. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-4598-3-19","article-title":"Mutation in mitochondrial complex I ND6 subunit is associated with defective response to hypoxia in human glioma cells","volume":"3","author":"DeHaan","year":"2004","journal-title":"Mol. Cancer"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1038\/s41598-017-07757-w","article-title":"Use antibiotics in cell culture with caution: Genome-wide identification of antibiotic-induced changes in gene expression and regulation","volume":"7","author":"Ryu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_102","first-page":"301","article-title":"Analysis of cell cycle by flow cytometry","volume":"281","author":"Pozarowski","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.hoc.2017.02.001","article-title":"Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric Adenocarcinoma","volume":"31","author":"Anandappa","year":"2017","journal-title":"Hematol. Oncol. Clin. N. Am."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/5090\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:18:10Z","timestamp":1780719490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/5090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":103,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27115090"],"URL":"https:\/\/doi.org\/10.3390\/ijms27115090","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}